TechEarnings
517 views
2 Discussing
Hot
Latest
I just chill fr and earn BTTC with this
If you have extra spare equipment and feeling like earning extra BTTC then this is the best software I guess
Have any question? comment below
#SpareGear #MiningRig #TechHustle #PutYourGearToWork #TechEarnings #UtilizeYourHardware
If you have extra spare equipment and feeling like earning extra BTTC then this is the best software I guess
Have any question? comment below
#SpareGear #MiningRig #TechHustle #PutYourGearToWork #TechEarnings #UtilizeYourHardware
S&P 500 HITS 6,400 BEFORE SLIDING – TECH GAINS FADE INTO BROADER WEAKNESS
The S&P 500 briefly surged past 6,400 for the first time in history Thursday, but bullish momentum couldn’t hold. Despite record-setting intraday highs for both the S&P 500 and Nasdaq, the broader market turned red by the close.
🔻 Closing Stats:
• S&P 500: -0.4%
• Nasdaq: -0.1%
• Dow Jones: -0.6% (-283 pts)
Early gains were driven by strong tech earnings. Microsoft jumped 4% after crushing expectations and revealing Azure’s $75B annual revenue run rate—pushing its market cap past $4T. Meta soared 12% on a bullish Q3 forecast.
But tech couldn’t save the rest: UnitedHealth and Merck sank 5% and 4%, dragging the Dow. Six of eleven S&P sectors closed lower, led by healthcare.
💬 “Strong earnings and buybacks aren’t enough anymore,” said Joseph Cusick of Calamos Investments. “Market reactions are harder to justify.”
Macro Pressures Build:
• Fed policy uncertainty clouds the outlook on rate cuts.
• U.S. tariff threats intensify, with new duties looming on India, Brazil, and an extension on Mexican imports.
• U.S.–China trade talks stall ahead of the August 12 deadline, raising fears of renewed tariffs.
Meanwhile, pharma stocks suffered another blow. Trump’s crackdown on drug prices hit Merck, Pfizer, and Eli Lilly, while Novo Nordisk tumbled nearly 5% after an HSBC downgrade. Analysts say the GLP-1 weight-loss drug boom is “maturing,” with slower growth expected.
IPOs Still Pop:
Figma launched on NYSE at $85, more than doubling its $33 IPO price. Volatility briefly paused trading—but it shot past $100 minutes later.
Despite Thursday’s drop, July ends in the green:
• S&P 500: +2%
• Nasdaq: +3%
• Dow: +0.4%
Eyes now turn to Apple and Amazon earnings after the bell.
#StockMarket #S&P500 #TechEarnings #Write2Earn
The S&P 500 briefly surged past 6,400 for the first time in history Thursday, but bullish momentum couldn’t hold. Despite record-setting intraday highs for both the S&P 500 and Nasdaq, the broader market turned red by the close.
🔻 Closing Stats:
• S&P 500: -0.4%
• Nasdaq: -0.1%
• Dow Jones: -0.6% (-283 pts)
Early gains were driven by strong tech earnings. Microsoft jumped 4% after crushing expectations and revealing Azure’s $75B annual revenue run rate—pushing its market cap past $4T. Meta soared 12% on a bullish Q3 forecast.
But tech couldn’t save the rest: UnitedHealth and Merck sank 5% and 4%, dragging the Dow. Six of eleven S&P sectors closed lower, led by healthcare.
💬 “Strong earnings and buybacks aren’t enough anymore,” said Joseph Cusick of Calamos Investments. “Market reactions are harder to justify.”
Macro Pressures Build:
• Fed policy uncertainty clouds the outlook on rate cuts.
• U.S. tariff threats intensify, with new duties looming on India, Brazil, and an extension on Mexican imports.
• U.S.–China trade talks stall ahead of the August 12 deadline, raising fears of renewed tariffs.
Meanwhile, pharma stocks suffered another blow. Trump’s crackdown on drug prices hit Merck, Pfizer, and Eli Lilly, while Novo Nordisk tumbled nearly 5% after an HSBC downgrade. Analysts say the GLP-1 weight-loss drug boom is “maturing,” with slower growth expected.
IPOs Still Pop:
Figma launched on NYSE at $85, more than doubling its $33 IPO price. Volatility briefly paused trading—but it shot past $100 minutes later.
Despite Thursday’s drop, July ends in the green:
• S&P 500: +2%
• Nasdaq: +3%
• Dow: +0.4%
Eyes now turn to Apple and Amazon earnings after the bell.
#StockMarket #S&P500 #TechEarnings #Write2Earn
Login to explore more contents